About
Sivan Innovation serves healthcare professionals and patients by designing, evaluating, validating, and developing web applications for disease management.
The company is the developer of Moovcare, a digital therapy designed for cancer patients. The application is based on a smart algorithm that can detect relapses and complications and sends immediate alerts to the medical team. Patients with lung cancer report their symptoms via a weekly digital questionnaire, enabling the oncologist to act if needed.
Moovcare is reimbursed by health authorities in France and has demonstrated an increase of 7.6 months in overall survival as well as a significant improvement in quality of life.
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is Sivan Innovation's primary product?
- Sivan Innovation's primary product is Moovcare, a digital therapy for cancer patients.
- What is the core functionality of Moovcare?
- Moovcare uses a smart algorithm to detect relapses and complications in cancer patients, sending immediate alerts to the medical team. It enables lung cancer patients to report symptoms weekly via a digital questionnaire.
- In which country is Moovcare reimbursed by health authorities?
- Moovcare is reimbursed by health authorities in France.
- What clinical benefit has Moovcare demonstrated?
- Moovcare has demonstrated an increase of 7.6 months in overall survival and a significant improvement in quality of life for patients.
- When was Sivan Innovation founded?
- Sivan Innovation was founded in June 2014.
- Where is Sivan Innovation's headquarters located?
- Sivan Innovation's headquarters is located in Ra'anana, Israel.
- Does Sivan Innovation have offices outside of Israel?
- Yes, Sivan Innovation has an office in Paris, France.
- What are Sivan Innovation's key geographic markets?
- Sivan Innovation's key geographic markets include Germany, the United States, France, and Israel.
- What was a notable finding from a study published in June 2018 related to Sivan Innovation's work?
- In June 2018, a study highlighted the value of patient-reported outcomes (PROs) in improving lung cancer survival, a core aspect of Moovcare's functionality.